- Home
- NTGR vs RAPP Comparison
NTGR vs RAPP Comparison
Compare NTGR & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTGR
- RAPP
- Stock Information
- Founded
- NTGR 1996
- RAPP 2022
- Country
- NTGR United States
- RAPP United States
- Employees
- NTGR N/A
- RAPP N/A
- Industry
- NTGR Telecommunications Equipment
- RAPP
- Sector
- NTGR Utilities
- RAPP
- Exchange
- NTGR Nasdaq
- RAPP Nasdaq
- Market Cap
- NTGR 801.8M
- RAPP 508.4M
- IPO Year
- NTGR N/A
- RAPP 2024
- Fundamental
- Price
- NTGR $28.23
- RAPP $17.78
- Analyst Decision
- NTGR Hold
- RAPP Strong Buy
- Analyst Count
- NTGR 1
- RAPP 4
- Target Price
- NTGR $13.00
- RAPP $37.33
- AVG Volume (30 Days)
- NTGR 296.1K
- RAPP 98.0K
- Earning Date
- NTGR 02-05-2025
- RAPP 02-14-2025
- Dividend Yield
- NTGR N/A
- RAPP N/A
- EPS Growth
- NTGR N/A
- RAPP N/A
- EPS
- NTGR 0.66
- RAPP N/A
- Revenue
- NTGR $680,014,000.00
- RAPP N/A
- Revenue This Year
- NTGR N/A
- RAPP N/A
- Revenue Next Year
- NTGR $6.07
- RAPP N/A
- P/E Ratio
- NTGR $42.88
- RAPP N/A
- Revenue Growth
- NTGR N/A
- RAPP N/A
- 52 Week Low
- NTGR $10.48
- RAPP $12.10
- 52 Week High
- NTGR $31.55
- RAPP $29.74
- Technical
- Relative Strength Index (RSI)
- NTGR 53.84
- RAPP N/A
- Support Level
- NTGR $25.47
- RAPP N/A
- Resistance Level
- NTGR $28.32
- RAPP N/A
- Average True Range (ATR)
- NTGR 0.90
- RAPP 0.00
- MACD
- NTGR -0.05
- RAPP 0.00
- Stochastic Oscillator
- NTGR 60.78
- RAPP 0.00
About NTGR NETGEAR Inc.
Netgear Inc is a provider of networking solutions. The reportable segments of the company are connected home, and Small and Medium Businesses (SMB). The Connected Home segment focuses on consumers and consists of high-performance, dependable, and easy-to-use 4G/5G mobile, Wi-Fi internet networking solutions, and smart devices such as Orbi Voice smart speakers and Meural digital canvas; and NETGEAR specializes in providing networking solutions for businesses, including wireless LAN, Pro AV applications for audio and video over Ethernet, security, and remote management.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.